PofoliaShared via Pofolia

Nucleic Acids Research· 2025Q1

The IPD-IMGT/HLA database: recent developments in sequence submission

Dominic J. Barker, Richard H L Natarajan, Michael Cooper, Sebastian J. F. Hopper et al.

Short summary

The IPD-IMGT/HLA Database launched a new HLA Submission Tool and API, replacing a 26-year-old system to handle rapid growth in HLA sequencing and reduce submitter workload.

AI-generated from the title and abstract; the full text is not read.

Key points

  • The IPD-IMGT/HLA Database now features a new HLA Submission Tool and API to manage >43,000 unique alleles from 47 HLA genes.
  • The new tool replaces a system used for over 26 years and over 28,000 submissions.
  • Features include a streamlined user experience, extensive data validation, and automated submissions via API.
  • Optional brokering to the European Nucleotide Archive (ENA) prevents duplicate submissions and ensures attribution.

AI-generated from the title and abstract; the full text is not read.

Abstract

The IPD-IMGT/HLA Database, https://www.ebi.ac.uk/ipd/imgt/hla/, contains >43 000 unique alleles from 47 genes recognized by the WHO Nomenclature Committee for Factors of the HLA System. The HLA system, located within the human major histocompatibility complex on chromosome 6, represents the most polymorphic genes in the human genome and is described as hyperpolymorphic. With the rapid growth of HLA sequencing worldwide, traditional approaches for submitting and accessing data have been challenged. To address these challenges, the IPD-IMGT/HLA Database has expanded its infrastructure by developing Application Programming Interfaces, enabling flexible queries via both a web-based interface and programmatic access. A major advancement is the launch of a new HLA Submission Tool, replacing the previous system after 26 years and >28 000 submissions. The updated tool provides a streamlined user experience, extensive data validation, and automated submissions through an application program interface (API). Importantly, it eliminates the burden of duplicate submissions by offering optional brokering to the European Nucleotide Archive on our submitters' behalf, representing sequences in both databases while ensuring attribution. Together, the new submission tool, submission API, and ENA brokering reduce workload, increase efficiency, and provide ongoing support for the global HLA community.

The authors' abstract, as published at the source. Nucleic Acids Research, 2025 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Information Systems

Information SystemsComputer Science